Skip to main content
Discovering the causes of cancer and the means of prevention
 

Transgender Patients and Cancer Disparities

, by DCEG Staff

Text reads: Cancer in transgender people

Transgender people may be diagnosed at later stages, be less likely to receive treatment, and have worse survival for several cancer types, compared to cisgender patients, according to a study published March 10, 2020, in the Journal of the National Cancer Institute.

The National Transgender Discrimination Survey from 2015 showed that transgender individuals, whose gender identity differs from their sex assigned at birth, experience many barriers to healthcare access, including lack of insurance and discrimination in medical settings. These barriers may delay diagnosis and treatment of cancer and result in decreased survival of transgender patients, however data on cancer in this population are limited since most medical records do not collect gender identity.

Sarah Jackson, Ph.D., postdoctoral fellow in the Infections and Immunoepidemiology Branch, and colleagues, examined the National Cancer Database to investigate the association between gender identity and diagnosis, treatment, and survival of cancer. They found that transgender patients with non-Hodgkin lymphoma, prostate cancer, or bladder cancer were twice as likely to die than cisgender patients. In addition, they found transgender patients might be twice as likely to be diagnosed at later stages for lung cancer and 70-80 percent less likely to receive treatment if they had kidney or pancreatic cancer.

Results of this study highlight the need to improve the collection of gender identity data separate from sex assigned at birth to facilitate research on this underserved community.

Reference

Jackson SS et al. Cancer stage, treatment, and survival among transgender patients in the United States. J Natl Cancer Inst. March 2021. DOI: 10.1093/jnci/djab028. [Epub before print].

< Older Post

2021 NCI Intramural Scientific Investigators Retreat, Highlights

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Transgender Patients and Cancer Disparities was originally published by the National Cancer Institute.”